HAMBURG, Germany — A combination of the antiviral drugs pleconaril and ribavirin slowed the decline of pancreatic insulin production compared with placebo in children and adolescents with newly ...

Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today's decision by the U.S. Food and Drug Administration (FDA) to approve Sanofi ...

CLEVELAND, Ohio — Before her pregnancy, Katherine Hegedorn of Parma was a healthy marathon runner. But during her recent pregnancy, she developed gestational diabetes, or high blood sugar, which can ...

Researchers identify genetic markers that predict the rate of β-cell failure in type 1 diabetes, facilitating earlier, personalized care strategies Type 1 diabetes (T1D) is an autoimmune condition ...

A groundbreaking new drug that slows down the development of type 1 diabetes has been licensed for use in the UK. Teplizumab can allow patients to live “normal lives” without the need for insulin ...

Insulin resistance usually develops quietly, without any clear warning signs. There isn’t a sudden symptom that signals its ...

Stress does no one — not even your insulin-producing cells — any good. Researchers from Osaka Metropolitan University have identified a gene that, when activated by metabolic stress, damages ...

A genetic predisposition to having lower insulin production and less healthy fat distribution are major causes of early-onset type 2 diabetes in British Asian people. According to research, these ...

VIENNA — Two experts from the UK who spoke at the European Association for the Study of Diabetes (EASD) 2025 Annual Meeting offered advice for avoiding misdiagnosis of adults who present with diabetes ...